I want to express my gratitude to Sen. Bob Casey for his steadfast dedication to the fight against Alzheimer’s disease during ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

Dear Quentin,  I have two sisters who have developed Alzheimer’s disease. My younger sister is actually more severely ...

While food and lifestyle changes can't completely reverse the effects of Alzheimer's disease, your plate could go a long way ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the ...

Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the ...

Alector is kicking off a resource realignment effort that will include a workforce reduction of around 17%. The biotech ...

In mice, inhibiting protein S-palmitoylation Counteracted accumulation of harmful proteins in neurons and delayed onset and progression of cognitive decline.

Imagine gradually losing the ability to express yourself—not because you've forgotten the words, but because they simply ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...